Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.

Published on Mar 28, 2020in International Urology and Nephrology1.843
· DOI :10.1007/S11255-020-02451-9
Brandon Michael Henry33
Estimated H-index: 33
(Cincinnati Children's Hospital Medical Center),
Giuseppe Lippi109
Estimated H-index: 109
(University of Verona)
📖 Papers frequently viewed together
107 Citations
1,412 Citations
181 Citations
#1Dawei Wang (WHU: Wuhan University)H-Index: 6
#2Bo Hu (WHU: Wuhan University)H-Index: 3
Last. Zhiyong Peng (WHU: Wuhan University)H-Index: 21
view all 14 authors...
Importance In December 2019, novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited. Objective To describe the epidemiological and clinical characteristics of NCIP. Design, Setting, and Participants Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University in Wu...
9,342 CitationsSource
#1Weijie Guan (Guangzhou Medical University)H-Index: 14
#2Zhengyi Ni (Guangzhou Medical University)H-Index: 6
Last. Nanshan Zhong (Guangzhou Medical University)H-Index: 69
view all 37 authors...
Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of...
11.1k CitationsSource
#1Jin-jin Zhang (WHU: Wuhan University)H-Index: 5
#2Xiang Dong (WHU: Wuhan University)H-Index: 6
Last. Ya-dong Gao (WHU: Wuhan University)H-Index: 10
view all 8 authors...
BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2. METHODS: Electronic medical records including demographics, clinical manifestation, comorbidities, laboratory data, and radiological materials of 140 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection, were ...
1,545 CitationsSource
#1Yingxia Liu (Southern University of Science and Technology)H-Index: 32
#2Yang Yang (Southern University of Science and Technology)H-Index: 4
Last. Lei Liu (Southern University of Science and Technology)H-Index: 42
view all 22 authors...
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei province, and rapidly spread to many provinces in China as well as other countries. Here we report the epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China. All 12 cases of the 2019-nCoV-infected patients developed pneumonia and half of them developed acute respiratory distress syndrome...
856 CitationsSource
#1Che-Yi Chou (PRC: China Medical University (PRC))H-Index: 21
#2Shu-Ming WangH-Index: 9
Last. Ruey-Yun WangH-Index: 5
view all 10 authors...
Patients with chronic kidney disease (CKD) are more at risk for pneumonia than the general population. Patients with pneumonia are usually treated as outpatients. However, previous studies were con- ducted on the basis of inpatient pneumonia. This method may under- estimate the risk of pneumonia in patients with CKD. Therefore, we investigated the risk of pneumonia among CKD patients in both out- patient and inpatient settings. A total of 15,562 patients with CKD and 62,109 individuals without C...
31 CitationsSource
#1Mark J. Sarnak (Tufts University)H-Index: 108
#2Bertrand L. Jaber (Tufts University)H-Index: 64
Background Infection is the second-leading cause of death among patients with end-stage renal disease (ESRD). This is due in part to advanced age, comorbid conditions, and immune dysfunction observed in uremic states. Although one may hypothesize that pulmonary infectious mortality is higher among patients with ESRD compared with the general population (GP), no such data are currently available. Methods We compared annual pulmonary infectious mortality rates among patients with ESRD to those in ...
208 CitationsSource
Cited By165
#1Rajen Parekh (UNC: University of North Carolina at Chapel Hill)H-Index: 1
#2Xian Zhang (UNC: University of North Carolina at Chapel Hill)H-Index: 4
Last. Michael D. Kappelman (UNC: University of North Carolina at Chapel Hill)H-Index: 49
view all 0 authors...
Comorbidities increase the risk of coronavirus disease 2019 (COVID-19) hospitalization and mortality. As many comorbidities are common in patients with inflammatory bowel diseases (IBD), we sought to investigate the effects of comorbidities in these patients on infection severity. To evaluate association between individual comorbidities and COVID-19 infection severity among patients with IBD. Data were obtained from SECURE-IBD, an international registry created to evaluate COVID-19 outcomes in p...
1 CitationsSource
#1In Sook Kang (Ewha Womans University)
#2Kyoung Ae Kong (Ewha Womans University)H-Index: 17
Objective Obesity has been reported as a risk factor for severe coronavirus disease 2019 (COVID-19) in recent studies. However, the relationship between body mass index (BMI) and COVID-19 severity and fatality are unclear. null null Research design and methods This study included 4,141 COVID-19 patients who were released from isolation or had died as of April 30, 2020. This nationwide data was provided by the Korean Centers for Disease Control and Prevention Agency. BMI was categorized as follow...
#2Kevin Bryan LoH-Index: 10
Last. Gabriel Patarroyo AponteH-Index: 2
view all 0 authors...
Introduction While Coronavirus disease 2019 (COVID-19) specific treatments have been instituted, overall mortality rates among hospitalized patients remain significant. Our study aimed to evaluate patient clinical characteristics and outcomes comparing the different COVID-19 infection peak periods. Methods This is a retrospective study of all adult patients hospitalized with a confirmed diagnosis of COVID-19 between March 1 to April 24, 2020 and November 1 to December 31, 2020, which corresponde...
Background Emerging evidence links acute kidney injury (AKI) in patients with COVID-19 with higher mortality and respiratory morbidity, but the relationship of AKI with cardiovascular disease outcomes has not been reported in this population. We sought to evaluate associations between chronic kidney disease (CKD), AKI, and mortality and cardiovascular outcomes in patients hospitalized with COVID-19. Methods and Results In a large multicenter registry including 8574 patients with COVID-19 from 88...
Background The novel coronavirus (COVID-19), caused by SARS-CoV-2, showed various prevalence and case-fatality rates (CFR) among patients with different pre-existing chronic conditions. End-stage renal disease (ESRD) patients with renal replacement therapy (RRT) might have a higher prevalence and CFR due to reduced immune function from uremia and kidney tropism of SARS-CoV-2, but there was a lack of systematic study on the infection and mortality of the SARS-CoV-2 infection in ESRD patients with...
#1Stephanie L Harrison (University of Liverpool)H-Index: 19
#2Benjamin J R Buckley (University of Liverpool)H-Index: 3
Last. Gregory Y.H. Lip (University of Liverpool)H-Index: 195
view all 0 authors...
Aims null To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health. null Methods and results null An umbrella review of systematic reviews was conducted. Fourteen medical databases and pre-print servers were searched from 1 January 2020 to 5 November 2020. The review focused on reviews rated as moderate or high-quality using the AMSTAR 2 tool. Eighty-...
#1Savas Ozturk (Istanbul University)H-Index: 13
#2Kenan Turgutalp (Mersin University)H-Index: 9
Last. Kenan Ates (Ankara University)H-Index: 20
view all 34 authors...
OBJECTIVE Older adults with comorbidities have been reported to be at higher risk for adverse outcomes of Coronavirus disease 2019(COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known. METHODS Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between April 17, 2020, and December 31, 2020. Hospitalized patients...
After the announcement of a new coronavirus in China in December 2019, which was then called SARS-CoV-2, this virus changed to a global concern and it was then declared as a pandemic by WHO Human leukocyte antigen (HLA) alleles, which are one of the most polymorphic genes, play a pivotal role in both resistance and vulnerability of the body against viruses and other infections as well as chronic diseases The association between HLA alleles and preexisting medical conditions such as cardiovascula...
#1I. Pecly (Estácio S.A.)
#2Rafael Bellotti Azevedo (Estácio S.A.)H-Index: 1
Last. Cibele Isaac Saad Rodrigues (PUC-SP: Pontifícia Universidade Católica de São Paulo)H-Index: 9
view all 8 authors...
Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with higher mortality and a worse prognosis. Nevertheless, most patients with COVID-19 have mild symptoms, and about 5% can develop more severe symptoms and involve hypovolemia and multiple organ dysfunction syndrome. In a pathophysiological perspective, severe SARS-CoV-2 infection is characterized by numerous dependent pathways triggered by hypercytokinemia, especially IL-6 and TNF-alpha, leading to systemic inflamma...